Evidence map›Paper›PMID 40596890›Full record

ReviewBMC infectious diseases2025

Recurrent knee septic arthritis and osteomyelitis due to Candida viswanathii: a case report and literature review.

Narmadha Morvil, Hei Man Wong

Abstract readCase ReportsReview
In one paragraph

Review in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The Yeast in the Vial: IatrogenicJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Multicentre outbreak ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  3. UnmaskingPathogens (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Narmadha MorvilDepartment of Infectious Diseases, Singapore General Hospital, The Academia, Level 3, 20 College Rd, Singapore, 169856, Singapore. narmadha.morvil@mohh.com.sg.
Hei Man WongDepartment of Infectious Diseases, Singapore General Hospital, The Academia, Level 3, 20 College Rd, Singapore, 169856, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCandida viswanathii is a rare Candida with fewer than 40 clinical cases of infection reported globally and with limited treatment descriptions available. Here we report a rare case of recurrent candida septic arthritis and osteomyelitis caused by C. viswanathii. CASE PRESENTATION: A 78-year-old Chinese female developed her first episode of C. viswanathii septic arthritis and osteomyelitis likely following intra-articular lignocaine injections to her left knee. She was treated with 2 surgical washouts and 16 months of antifungal agents, which included an initial 6 months of voriconazole followed by fluconazole, with full recovery. However, she presents with recurrence of left knee pain 14 months after antifungal therapy was stopped. Open arthrotomy revealed extensive synovitis and granulation tissue, with a sinus tract extending to the anterior patella. C. viswanathii was re-cultured in her synovial fluid and identified via a combination of fungal phenotypic tests and DNA sequencing of the ITS region and the D1/D2 region of the 28 S ribosomal subunit. She was managed with two open knee arthrotomies, drainage with curettage and debridement, and was reinitiated on oral voriconazole therapy, to which she demonstrated a good clinical response. She was subsequently maintained on chronic suppressive oral voriconazole therapy. Her symptoms remain well controlled, and no relapse was observed on the last follow-up. Additionally, we have also done a comprehensive literature review of all the published clinical cases of C. viswanathii thus far.

conclusionThis is the first case report to describe the successful treatment and monitoring of recurrent C. viswanathii osteoarticular infection. Combined with our literature review, we aim to increase understanding of this rare candida species- specifically its clinical trajectory in osteoarthritic infections, laboratory features, radiological characteristics, intra-operative findings, and treatment aspects inclusive of a potential role for long-term suppressive therapy.

Indexed as

Arthritis, InfectiousCandidaCandidiasisKnee JointOsteomyelitisAgedAntifungal AgentsFemaleHumansRecurrenceVoriconazoleAntifungal AgentsVoriconazoleCandida viswanathiiCase reportChronic suppressive voriconazoleKnee jointRecurrent arthritis

Identifiers

PMID40596890
PMCPMC12217292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.